Table 1.
Patient and disease characteristics.
| Patient age/sex/race | Traditional hospital admission CRP (mg/dL) | Traditional hospital admission endoscopic Mayo score | Traditional hospital admission albumin (g/dL) | CRP at the time of transfer to HaH (mg/dL) | ASUC therapeutics at the time of transfer to HaH | Discharge CRP (mg/dL) |
|---|---|---|---|---|---|---|
| 36/Male/Caucasian | 21.2 | Mayo 3 | 3.1 | 0.7 | IV Methylprednisolone, cyclosporine | 0.7 |
| 70/Female/Caucasian | 8.7 | Mayo 3 | 3.2 | 3.3 | IV Methylprednisolone and infliximab × 2 doses | 2.7 |
| 73/Female/Caucasian | 23.5 | Mayo 3 | 4.1 | 7.1 | IV Methylprednisolone and infliximab × 1 dose | 1.1 |